Stock Track | Ardelyx Shares Soar 6.92% Pre-market on Impressive Q4 Earnings Beat

Stock Track

20 Feb

Ardelyx Inc. (ARDX) shares surged 6.92% in the pre-market trading session on Thursday, following the company's impressive fourth-quarter 2024 earnings results that surpassed analyst estimates.

The biopharmaceutical company reported quarterly earnings of $0.02 per share, beating the consensus estimate of $0.01 by 100%. This marked a significant improvement from the loss of $0.12 per share reported in the same period last year. Ardelyx's revenue for the quarter stood at $116.13 million, a remarkable 237.95% year-over-year increase, and also exceeded the analyst consensus estimate of $109.94 million by 5.63%.

The strong financial performance and better-than-expected results suggest that Ardelyx's products and pipeline are gaining traction, driving investor optimism and propelling the stock higher in the pre-market trading session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

no data

No relevant data is available

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1112908603"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1112908603\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1112908603?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-20 20:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1112908603","market":"us","top_or_hot":-1,"title":"Stock Track | Ardelyx Shares Soar 6.92% Pre-market on Impressive Q4 Earnings Beat","media":"Stock Track","content":"<p>Ardelyx Inc. (ARDX) shares surged 6.92% in the pre-market trading session on Thursday, following the company's impressive fourth-quarter 2024 earnings results that surpassed analyst estimates.</p>\n\n<p>The biopharmaceutical company reported quarterly earnings of $0.02 per share, beating the consensus estimate of $0.01 by 100%. This marked a significant improvement from the loss of $0.12 per share reported in the same period last year. Ardelyx's revenue for the quarter stood at $116.13 million, a remarkable 237.95% year-over-year increase, and also exceeded the analyst consensus estimate of $109.94 million by 5.63%.</p>\n\n<p>The strong financial performance and better-than-expected results suggest that Ardelyx's products and pipeline are gaining traction, driving investor optimism and propelling the stock higher in the pre-market trading session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Ardelyx Shares Soar 6.92% Pre-market on Impressive Q4 Earnings Beat</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Ardelyx Shares Soar 6.92% Pre-market on Impressive Q4 Earnings Beat\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-20 20:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ardelyx Inc. (ARDX) shares surged 6.92% in the pre-market trading session on Thursday, following the company's impressive fourth-quarter 2024 earnings results that surpassed analyst estimates.</p>\n\n<p>The biopharmaceutical company reported quarterly earnings of $0.02 per share, beating the consensus estimate of $0.01 by 100%. This marked a significant improvement from the loss of $0.12 per share reported in the same period last year. Ardelyx's revenue for the quarter stood at $116.13 million, a remarkable 237.95% year-over-year increase, and also exceeded the analyst consensus estimate of $109.94 million by 5.63%.</p>\n\n<p>The strong financial performance and better-than-expected results suggest that Ardelyx's products and pipeline are gaining traction, driving investor optimism and propelling the stock higher in the pre-market trading session.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ARDX","symbol_name":"Ardelyx","start_time":0,"source_url":"","article_id":"1112908603","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1112908603","pubTimestamp":1740055252,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Ardelyx Inc.  shares surged 6.92% in the pre-market trading session on Thursday, following the company's impressive fourth-quarter 2024 earnings results that surpassed analyst estimates.The biopharmaceutical company reported quarterly earnings of $0.02 per share, beating the consensus estimate of $0.01 by 100%. This marked a significant improvement from the loss of $0.12 per share reported in the same period last year. Ardelyx's revenue for the quarter stood at $116.13 million, a remarkable 237.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ARDX":"Ardelyx"},"translate_title":"股票追踪Ardelyx股价盘前飙升6.92%，第四季度盈利令人印象深刻","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ARDX":1},"content_text":"Ardelyx Inc. (ARDX) shares surged 6.92% in the pre-market trading session on Thursday, following the company's impressive fourth-quarter 2024 earnings results that surpassed analyst estimates.\nThe biopharmaceutical company reported quarterly earnings of $0.02 per share, beating the consensus estimate of $0.01 by 100%. This marked a significant improvement from the loss of $0.12 per share reported in the same period last year. Ardelyx's revenue for the quarter stood at $116.13 million, a remarkable 237.95% year-over-year increase, and also exceeded the analyst consensus estimate of $109.94 million by 5.63%.\nThe strong financial performance and better-than-expected results suggest that Ardelyx's products and pipeline are gaining traction, driving investor optimism and propelling the stock higher in the pre-market trading session.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0}}}

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."

Consult now
Download APP
Scan QR code to download the app.